Boston Scientific (BSX) Short-Term Debt issuances (2017 - 2025)

Boston Scientific has disclosed Short-Term Debt issuances across 8 years of filings, most recently posting -$192.0 million for Q1 2025.

• Short-Term Debt issuances for Q1 2025 came in at -$192.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.0 million (changed 0.0% YoY), and the FY2025 annual result was -$196.0 million, down 204.81% from the prior year.
• Short-Term Debt issuances came in at -$192.0 million for Q1 2025 at Boston Scientific, down from $187.0 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $223.0 million in Q1 2022 to a low of -$192.0 million in Q1 2025.
• The 4-year median for Short-Term Debt issuances is -$4.0 million (2023), against an average of -$1.0 million.
• Across the five-year window, Short-Term Debt issuances sank 500.0% in 2023 and jumped 4775.0% in 2024, its largest moves.
• Boston Scientific's Short-Term Debt issuances stood at $1.0 million in 2022, then tumbled by 500.0% to -$4.0 million in 2023, then surged by 4775.0% to $187.0 million in 2024, then sank by 202.67% to -$192.0 million in 2025.
• The last three Short-Term Debt issuances figures came in at -$192.0 million (Q1 2025), $187.0 million (Q4 2024), and -$4.0 million (Q4 2023), per Business Quant data.